Company intelligence / Profile preview
VITRUVIAN BioMedical, Inc.
Addison, Texas, United Statesvitruvianbiomedical.com ↗
- Ownership
- Private
- Employees
- ~10
- Development stage
- Preclinical
01
Overview
Vitruvian BioMedical has developed therapeutic vaccine candidates targeting ABeta and TAU for Alzheimer’s Disease. Both main programs are in the preclinical stage with no active clinical trials currently registered. The company also develops diagnostic blood tests for early detection of Alzheimer's Disease.
- Therapeutic areas
- OncologyMetabolic DisordersNeurology
- Modalities
- Therapeutic vaccines (including DNA and mRNA vaccines)diagnostics
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
03
Partnerships
Key partners in biotech/pharma industry mentioned but none specifically named
Beyond the preview
Go deeper on VITRUVIAN BioMedical, Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on VITRUVIAN BioMedical, Inc..